According to our new research study on "Antimicrobial Surgical Suture Market Forecast to 2031 - Global Analysis - by Type, Raw Material, Application, End User, and Geography," the market is expected to grow from US$ 356.42 million in 2023 to US$ 755.95 million by 2031; it is estimated to record a CAGR of 9.9% from 2023-2031. Key factors driving the growth of the antimicrobial surgical suture market are the rising prevalence of surgical site infections and increasing cases of chronic wounds and surgeries. However, noninvasive alternatives to stitches hinder the market's growth.
The increasing number of cases of surgical site infections is driving the need for sutures that have antimicrobial properties. As per the National Library Medicine 2024 report, surgical site infections are responsible for more than 2 million nosocomial infections in the US. To fight against surgical site infections, scientists have developed nanosilver-impregnated silk sutures. Nanosilver possesses antimicrobial properties, and its optical and structural characteristics make it an appealing candidate for biomedical applications. Dolphin Sutures launched its antibacterial suture range containing triclosan coating in July 2022, which is a known broad-spectrum antibacterial and antifungal agent. Therefore, the increasing occurrence of surgical site infections creates demand for antimicrobial surgical sutures and drives the growth of the antimicrobial surgical sutures market.
The scope of the antimicrobial surgical suture market report includes the assessment of the market performance in North America, Europe, Asia Pacific, South & Central America, and the Middle East & Africa. Asia Pacific is anticipated to register the fastest CAGR in the antimicrobial surgical suture market from 2023 to 2031. The market in this region is expected to grow owing to factors such as rising plastic surgeries and increasing demand for medical tourism in emerging economies such as China and India. Moreover, the increase in the number of research studies and the surge in healthcare expenditure are anticipated to fuel market growth during the forecast period.
China performs more plastic surgery operations than any country except America. According to a report, over 22 million plastic surgeries were performed in China in 2020. This includes only the procedures performed by licensed plastic surgeons, which is likely higher due to the presence of unlicensed plastic surgeons in China. China's changing attitudes toward self-image, growing wealth, technological advancements, and obsession with celebrity culture fuel this growth. In China, beauty is deemed an advantage in the competitive mid-level workplace because job applicants are often required to submit a photograph with their application.
Apart from Plastic surgeries, orthopedic and general surgeries are also propelling the market for hospital sutures in China. In August 2020, Beijing Haidian Hospital officially introduced orthopedic surgery robots in May 2020 and completed more than 400 robotic surgeries by the end of August 2021. The orthopedic surgical robot could dynamically analyze the patient's anatomy and the spine-hip relation and carry out individualized surgery planning precisely as planned, facilitating the antimicrobial surgical suture market growth.
According to the International Society of Aesthetic Plastic Surgery, Japan holds more than one-fifth of the 1.3 million eyelid procedures worldwide. Along with eyelid surgery, hip replacement surgery is being done more in Japan. Japan has shown remarkable progress in the field of gastroenterological surgery, which includes the replacement of failed organs through transplantation, curative resection of cancers, and increased safety of undergoing major surgeries. Thus, the rate of deaths has decreased due to operative morbidity as there is an increase in the developments for minimal access surgery. Moreover, surgeons in Japan continue to contribute to the advances in gastroenterological surgery to address the crucial issues in gastroenterological surgery, supporting the antimicrobial surgical suture market growth. Thus, the factors mentioned above support the growth of antimicrobial surgical suture market.
India is among the world's fastest-developing nations and the leading countries in the Asia-Pacific region. India hosts ~17.78% of the total global population. The antimicrobial surgical suture market is expected to flourish during the forecast period owing to an increase in surgeries and lower cost of surgeries in the country.
The Lancet Commission for Global Surgery estimates that 5,000 surgeries are required to meet the surgical burden of disease for 100,000 people in low and middle-income countries such as India. According to the Ministry of Health and Family Welfare report, about two crore surgeries (requiring hospitalization and general anesthesia) were conducted in 2019-2020. C-section was the most performed surgery. Out of the two crore surgeries done in 2020, 80 lakhs were general (including haemorrhoidectomy, hernia, cholecystectomy, trauma, and laparoscopy surgeries), followed by 50 lakh gynecology surgeries, out of which up to 70% or 35,00,000 were C-sections. Neurology, orthopedic gastrointestinal, oncology, and cardiology surgeries stood at 10 lakhs each.
The minimal cost of surgeries in India attracts more foreign patients to visit the country for various types of treatments, increasing medical tourism in the country. The medical packages provided are very affordable to global health and wellness travelers. The leading hospitals in India have expertise in ophthalmology, cardiology, joint replacement, cardiothoracic surgery, urology, orthopedic surgery, gastroenterology, and multi-organ transplant surgery. All the surgeries are performed by expert surgeons who use the latest technological equipment at comparatively lower prices than the other countries in the Western region.
Thus, owing to the rise in medical tourism due to the lower cost of treatment, better facilities provided by the hospitals and better quality of treatments favor the growth of antimicrobial surgical suture market. These enable the conducting of a greater number of surgical procedures and eventually support the antimicrobial surgical suture market growth in the forecasted period.
TI Medical, Healthium Medtech Limited, Meril Life Sciences Pvt Ltd, Unilene, Johnson & Johnson, Boz Medical, Futura Surgicare Pvt Ltd (Dolphin Sutures), Cencora, Inc. (AmerisourceBergen Corporation), Advanced MedTech Solutions Pvt. Ltd., and Internacional Farmacéutica SA are among the leading companies profiled in the antimicrobial surgical suture market report.
Based on type, the antimicrobial surgical suture market is bifurcated into triclosan antimicrobial suture and chlorhexidine antimicrobial suture. Based on raw material, the market is categorized into polyglactin 910 antimicrobial suture, poliglecaprone 25, and polyglycolic acid. In terms of application, the market is segmented into cardiovascular surgery, general surgery, ophthalmic surgery, gynecological surgery, orthopedic surgery, plastic surgery, veterinary surgery, dental surgery, and others. Based on end user, the market is categorized into hospitals, ambulatory surgical centers, and others. Geographically, the antimicrobial surgical suture market is categorized into North America (US, Canada, and Mexico), Europe (France, Germany, UK, Spain, Italy, and Rest of Europe), Asia Pacific (China, India, Japan, Australia, South Korea, and Rest of Asia Pacific), the Middle East & Africa (Saudi Arabia, UAE, South Africa, and Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and Rest of South & Central America).
Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@premiummarketinsights.com